JPMorgan Chase & Co’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $248K | Sell |
28,161
-977
| -3% | -$8.61K | ﹤0.01% | 4378 |
|
|
2025
Q1 | $218K | Buy |
29,138
+1,648
| +6% | +$12.3K | ﹤0.01% | 4407 |
|
|
2024
Q4 | $229K | Buy |
27,490
+9,225
| +51% | +$76.9K | ﹤0.01% | 4484 |
|
|
2024
Q3 | $127K | Sell |
18,265
-400
| -2% | -$2.78K | ﹤0.01% | 4633 |
|
|
2024
Q2 | $91.5K | Buy |
18,665
+3,604
| +24% | +$17.7K | ﹤0.01% | 4636 |
|
|
2024
Q1 | $87.4K | Sell |
15,061
-11,833
| -44% | -$68.6K | ﹤0.01% | 4787 |
|
|
2023
Q4 | $176K | Buy |
26,894
+3,631
| +16% | +$23.8K | ﹤0.01% | 4511 |
|
|
2023
Q3 | $112K | Sell |
23,263
-4,411
| -16% | -$21.3K | ﹤0.01% | 4535 |
|
|
2023
Q2 | $141K | Buy |
27,674
+26,896
| +3,457% | +$137K | ﹤0.01% | 4467 |
|
|
2023
Q1 | $4K | Hold |
778
| – | – | ﹤0.01% | 5446 |
|
|
2022
Q4 | $4K | Sell |
778
-1,397
| -64% | -$7.18K | ﹤0.01% | 5277 |
|
|
2022
Q3 | $14K | Buy |
2,175
+613
| +39% | +$3.95K | ﹤0.01% | 5010 |
|
|
2022
Q2 | $7K | Sell |
1,562
-16,533
| -91% | -$74.1K | ﹤0.01% | 5250 |
|
|
2022
Q1 | $91K | Buy |
18,095
+3,990
| +28% | +$20.1K | ﹤0.01% | 4786 |
|
|
2021
Q4 | $123K | Sell |
14,105
-762
| -5% | -$6.65K | ﹤0.01% | 4745 |
|
|
2021
Q3 | $138K | Buy |
14,867
+3,895
| +35% | +$36.2K | ﹤0.01% | 4570 |
|
|
2021
Q2 | $141K | Buy |
+10,972
| New | +$141K | ﹤0.01% | 4646 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5409 |
|
|
2019
Q2 | – | Sell |
-134
| Closed | -$4K | – | 4965 |
|
|
2019
Q1 | $4K | Buy |
+134
| New | +$4K | ﹤0.01% | 4727 |
|
|
2018
Q3 | – | Sell |
-8,426
| Closed | -$876K | – | 4898 |
|
|
2018
Q2 | $876K | Buy |
8,426
+2,136
| +34% | +$222K | ﹤0.01% | 3196 |
|
|
2018
Q1 | $795K | Buy |
6,290
+6,251
| +16,028% | +$790K | ﹤0.01% | 3197 |
|
|
2017
Q4 | $3K | Sell |
39
-149
| -79% | -$11.5K | ﹤0.01% | 4588 |
|
|
2017
Q3 | $11K | Buy |
+188
| New | +$11K | ﹤0.01% | 4041 |
|
|
2017
Q2 | – | Sell |
-31
| Closed | -$2K | – | 4540 |
|
|
2017
Q1 | $2K | Sell |
31
-19
| -38% | -$1.23K | ﹤0.01% | 4356 |
|
|
2016
Q4 | $2K | Sell |
50
-55
| -52% | -$2.2K | ﹤0.01% | 4399 |
|
|
2016
Q3 | $8K | Buy |
+105
| New | +$8K | ﹤0.01% | 3880 |
|
|
2016
Q2 | – | Sell |
-1,323
| Closed | -$307K | – | 4367 |
|
|
2016
Q1 | $307K | Buy |
+1,323
| New | +$307K | ﹤0.01% | 3048 |
|
|
2015
Q3 | – | Sell |
-2,468
| Closed | -$726K | – | 3447 |
|
|
2015
Q2 | $726K | Buy |
+2,468
| New | +$726K | ﹤0.01% | 2957 |
|